Upstate Active Clinical Trials
Study Title:A Phase 3, Randomized, Observer-Blind, Placebo-Controlled, Group-Sequential Study to Determine the Immunogenicity and Safety of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine with Aluminium in Healthy Third-trimester Pregnant Women; and Safety and Efficacy of Maternally Transferred Antibodies in Preventing RSV Disease in their Infants
What is the purpose of the study?The main purpose of this study is to determine if giving the RSV F vaccine (against Respiratory Syncytial Virus) during the last trimester of pregnancy can prevent severe lung disease caused by RSV in their infants.
Upstate Institutional Review Board (IRB) Number:915692
Study Phase:Phase III
Patient Age Group:Children
Principal Investigator:Joseph B Domachowske
Who can I contact for more information?
Name: Lori J Ferguson